Palliative Care in Gynecologic Oncology Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Palliative Care in Gynecologic Oncology. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 1: A 60-year-old man with advanced prostate cancer presents with severe, constant back pain. X-ray reveals vertebral metastases. What is the most appropriate management?
- A. Chemotherapy
- B. Surgical decompression
- C. Radiation therapy (Correct Answer)
- D. NSAIDs
Palliative Care in Gynecologic Oncology Explanation: ***Radiation therapy***
- **Radiation therapy** is highly effective for localized pain control in **vertebral metastases** and can prevent further spinal cord compression [1].
- It works by shrinking the tumor, thereby alleviating pain and restoring neurological function in many cases.
*Chemotherapy*
- While chemotherapy is a systemic treatment for prostate cancer, its **pain-relieving effects are often slower** and less immediate compared to radiation for localized bone pain.
- It may be used in conjunction with radiation, but it is typically not the **most appropriate initial management** for severe, constant pain due to vertebral metastases.
*Surgical decompression*
- **Surgical decompression** is primarily considered for patients with **spinal cord compression** leading to neurological deficits or intractable pain unresponsive to radiation [1].
- The patient's presentation of severe, constant back pain due to vertebral metastases, without mentioned neurological compromise, makes **radiation therapy a more appropriate first-line treatment** in this context [1].
*NSAIDs*
- **NSAIDs** might provide some mild pain relief, but they are **insufficient for severe pain** caused by progressive vertebral metastases.
- They also carry risks like **gastrointestinal complications** and **renal impairment**, especially in elderly patients with advanced cancer.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 2: GATHER approach of counselling is used for
- A. Breaking any bad news
- B. Communication of breast cancer prognosis
- C. Contraceptives (Correct Answer)
- D. All of the options
Palliative Care in Gynecologic Oncology Explanation: ***Contraceptives***
- The **GATHER approach** (Greet, Ask, Tell, Help, Explain, Return) is a structured counseling model specifically designed for **family planning** and contraceptive guidance.
- It ensures a comprehensive discussion that empowers individuals to make informed choices about their **contraceptive methods**.
*Breaking any bad news*
- Counseling for breaking bad news often utilizes models like **SPIKES (Setting, Perception, Invitation, Knowledge, Emotions, Strategy and Summary)**, which focus on empathy and managing patient reactions.
- The GATHER approach is not specifically tailored for delivering difficult news, as its structure is more focused on information exchange and shared decision-making regarding a medical intervention.
*Communication of breast cancer prognosis*
- Communicating prognosis for serious illnesses like breast cancer requires a sensitive and nuanced approach, often integrating elements of **empathy, hope, and realistic expectations**.
- While general communication skills are important, the GATHER model's steps are not specifically designed for the delicate nature of discussing a cancer prognosis.
*All of the options*
- The GATHER model is a specialized tool, and while its principles may overlap with good communication in general, it is not universally applicable to all counseling scenarios.
- It is specifically optimized for guiding discussions and decisions related to **family planning and contraceptive use**.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 3: A 67-year-old female with hypertension and diabetes presents with heavy vaginal bleeding. What is the next step in management?
- A. Endometrial biopsy (Correct Answer)
- B. Pelvic ultrasound
- C. Detailed history and physical examination
- D. Complete blood count and coagulation studies
Palliative Care in Gynecologic Oncology Explanation: ***Endometrial biopsy***
- **Postmenopausal bleeding is endometrial cancer until proven otherwise** - this is a fundamental principle in gynecology requiring immediate tissue diagnosis.
- **Endometrial biopsy is the first-line investigation** for any postmenopausal woman presenting with vaginal bleeding, as per **ACOG, RCOG, and WHO guidelines**.
- An office endometrial biopsy (using **Pipelle sampler**) can be performed quickly and has **90-97% sensitivity** for detecting endometrial cancer and hyperplasia.
- In this 67-year-old patient with risk factors (hypertension, diabetes), direct tissue sampling is mandatory to rule out **endometrial carcinoma**, which is the most concerning etiology.
- If office biopsy is inadequate or negative but bleeding persists, proceed to **hysteroscopy with directed biopsy** or **dilatation and curettage (D&C)**.
*Pelvic ultrasound*
- While transvaginal ultrasound can assess **endometrial thickness** (cancer unlikely if <4-5mm in postmenopausal women), it **cannot replace histological diagnosis**.
- Ultrasound may be used as an **adjunct** or for **triage in resource-limited settings**, but in established postmenopausal bleeding, **tissue diagnosis takes priority**.
- Some protocols use ultrasound first, but the definitive diagnostic step remains biopsy, and many guidelines recommend proceeding directly to biopsy in postmenopausal bleeding.
*Detailed history and physical examination*
- History and examination are **always performed initially** when a patient presents, but the question asks for the "next step in management" after the presentation is established.
- These would have already been completed to confirm postmenopausal status, exclude obvious causes (trauma, atrophic vaginitis), and assess hemodynamic stability.
- The "next step" implies the specific diagnostic or therapeutic intervention to identify the cause.
*Complete blood count and coagulation studies*
- **CBC** helps assess the degree of anemia from blood loss and guides need for transfusion.
- **Coagulation studies** may identify bleeding disorders but are not routinely indicated unless clinical suspicion exists.
- These investigations are **supportive** but do not identify the **anatomical source** or **histological cause** of bleeding, which is essential for management of postmenopausal bleeding.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 4: Which of the following drugs is used for treatment of cancer associated thromboembolism?
- A. Direct factor Xa inhibitors
- B. Warfarin
- C. Anti-thrombin III inhibitors
- D. LMW heparin (Correct Answer)
Palliative Care in Gynecologic Oncology Explanation: ***LMW heparin***
- **Low molecular weight heparin (LMWH)** is the **preferred anticoagulant for cancer-associated thrombosis** due to its superior efficacy.
- It has a more predictable pharmacokinetic profile compared to unfractionated heparin and is administered subcutaneously.
*Direct factor Xa inhibitors*
- While effective for general venous thromboembolism (VTE) treatment, some direct oral anticoagulants (DOACs) like factor Xa inhibitors (e.g., rivaroxaban, apixaban) may be considered but have shown mixed results in comparative studies with LMWH for cancer patients, especially those with gastrointestinal cancers, presenting a **higher risk of major bleeding**.
- **LMWH** remains the **first-line choice**, especially in patients with active cancer, given the evidence for its greater efficacy and safety profile in this specific population.
*Warfarin*
- **Warfarin** is generally **not recommended** as a first-line treatment for cancer-associated thromboembolism due to its **drug interactions**, need for frequent monitoring (INR), and slower onset of action.
- Patients with cancer often have fluctuating nutritional status, hepatic dysfunction, and receive other medications that can significantly impact warfarin's effectiveness and safety.
*Anti-thrombin III inhibitors*
- **Antithrombin III inhibitors** (e.g., antithrombin concentrate) are primarily used in specific conditions like **hereditary antithrombin deficiency** or in cases of heparin resistance.
- They are **not a standard treatment** for cancer-associated thromboembolism in the general population of cancer patients.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 5: A 45-year-old female patient is told about the benefits and complications of a hysterectomy, and she agrees to the procedure. What kind of consent is this?
- A. Informed consent (Correct Answer)
- B. Implied consent
- C. Opt-out consent
- D. Passive consent
Palliative Care in Gynecologic Oncology Explanation: ***Informed consent***
- This type of consent occurs when a patient is fully educated about the proposed treatment, including its **benefits, risks, and alternatives**, and voluntarily agrees to proceed.
- It ensures the patient has adequate information to make an **autonomous decision** about their healthcare.
*Implied consent*
- This consent is inferred from a patient's **actions or conduct**, rather than being explicitly stated or written.
- Examples include extending an arm for a blood draw or arriving at an appointment for a specific test.
*Opt-out consent*
- This model assumes agreement unless the individual explicitly **refuses or declines** participation.
- It is commonly used in organ donation systems, where individuals are presumed donors unless they register otherwise.
*Passive consent*
- This usually refers to situations where explicit consent is not sought but also explicitly not denied, such as when parents are informed about a school health program and are given the opportunity to decline, but if they don't, consent is assumed.
- It is less formal than informed consent and typically used for **low-risk interventions** or data collection.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 6: Which of the following is an inappropriate indication for concomitant chemotherapy in cases of head and neck cancer?
- A. Metastatic advanced head and neck cancer (Correct Answer)
- B. As an organ-preserving method of treatment
- C. Primary treatment for patients with unresectable disease
- D. Postoperative case of intermediate stage resectable tumor
Palliative Care in Gynecologic Oncology Explanation: ***Metastatic advanced head and neck cancer***
- While chemotherapy is used in metastatic head and neck cancer, the term "concomitant chemotherapy" implies simultaneous administration with radiation therapy. For **metastatic disease**, the primary treatment strategy is usually **systemic chemotherapy** or targeted therapy, not necessarily concomitant with radiation to a local site with curative intent.
- Concomitant chemoradiation is primarily used for **locally advanced, non-metastatic disease** to improve local control and survival, not typically for systemic metastatic disease where the goal is palliation or systemic control.
*As an organ-preserving method of treatment*
- Concomitant chemoradiation is a well-established strategy for organ preservation, particularly in advanced laryngeal and pharyngeal cancers, allowing patients to avoid **laryngectomy** or extensive surgical resections while achieving similar oncologic outcomes.
- This approach aims to maintain **swallowing and speech function** by reducing tumor burden and eradicating microscopic disease.
*Primary treatment for patients with unresectable disease*
- For **unresectable locally advanced head and neck cancers**, concomitant chemoradiation is often considered the **definitive primary treatment** to achieve local control and improve survival outcomes.
- Surgery is not feasible in these cases due to tumor extent or involvement of critical structures, making chemoradiation the best curative option.
*Postoperative case of intermediate stage resectable tumor*
- **Adjuvant concomitant chemoradiation** is indicated postoperatively for resected tumors with high-risk features such as **extracapsular extension (ECE)** or positive surgical margins, even in intermediate stages.
- This is done to eradicate microscopic residual disease and reduce the risk of **local-regional recurrence**.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 7: What is the preferred method of contraception for a female with a family history of ovarian cancer?
- A. Progestin-only pills (POP)
- B. Copper intrauterine device (Cu IUCD)
- C. Condoms
- D. Combined oral contraceptive pills (OCP) (Correct Answer)
Palliative Care in Gynecologic Oncology Explanation: ***Combined oral contraceptive pills (OCP)***
- **OCPs** have been shown to significantly **reduce the risk of ovarian cancer by 30-50%**, with the protective effect increasing with duration of use.
- This protection is attributed to **suppression of ovulation**, reducing repetitive ovulation-related epithelial damage and inflammation that contributes to ovarian cancer development.
- The benefit **persists for years after discontinuation** and is particularly important for individuals with a family history of ovarian cancer, as it addresses a key modifiable risk factor.
- **First-line recommendation** for contraception in women with family history of ovarian cancer.
*Progestin-only pills (POP)*
- While **POPs** are effective contraceptives and generally safe, they do **not offer the same well-established protective effect against ovarian cancer** as combined hormonal contraceptives.
- Their primary mechanism is through thickening cervical mucus and suppressing ovulation, without the estrogen component.
- Evidence for ovarian cancer protection is limited compared to combined OCPs.
*Copper intrauterine device (Cu IUCD)*
- The **Cu IUCD** provides highly effective contraception by creating a local inflammatory response in the uterus that is spermicidal.
- It is a **non-hormonal method** and therefore does not impact the risk of ovarian cancer.
- Excellent contraceptive option for other indications, but not specifically protective against ovarian cancer.
*Condoms*
- **Condoms** primarily prevent pregnancy by blocking sperm from reaching the egg and are effective in preventing sexually transmitted infections.
- They are a **barrier method** and provide no hormonal protection against ovarian cancer.
- Useful for STI prevention but not relevant to ovarian cancer risk reduction.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 8: India is a country with different cultures and diverse languages. Which steps should a physician take to address the patient for better outcomes?
1. Insist on good communication
2. Insist on communication only via an interpreter
3. Treat them regardless of their cultural perceptions
4. The physician should consider the patient's religion and cultural perception
Select the correct combination:
- A. 1,4 (Correct Answer)
- B. 1,2
- C. 2,3
- D. 3,4
Palliative Care in Gynecologic Oncology Explanation: ***1,4***
- **Good communication** is paramount in healthcare, especially in a diverse country like India, to ensure **patient understanding**, **adherence** to treatment plans, and overall patient satisfaction.
- Considering a patient's **religion and cultural perceptions** allows the physician to tailor treatment and communication in a sensitive and **respectful manner**, fostering trust and better **health outcomes**.
*1,2*
- While good communication (1) is vital, **insisting solely on an interpreter** (2) may not always be feasible or necessary, particularly if the physician and patient share a common language or if the patient prefers direct communication. This can also disrupt the flow of rapport building.
- **Over-reliance on interpreters** can sometimes lead to misinterpretations or loss of non-verbal cues if the interpreter is not trained in medical interpretation.
*2,3*
- **Insisting only on an interpreter** (2) can be restrictive and may compromise direct patient-physician rapport, as discussed above.
- **Treating patients regardless of their cultural perceptions** (3) is an ethnocentric approach that can lead to mistrust, non-adherence, and ultimately **poor health outcomes** as it disregards the patient's beliefs and values regarding health and illness.
*3,4*
- **Treating patients regardless of their cultural perceptions** (3) can result in a lack of understanding and non-adherence if the treatment conflicts with the patient's deeply held beliefs.
- While considering religion and cultural perception (4) is crucial, this option includes an incorrect approach (3) that can undermine patient care.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 9: A 55-year-old woman is undergoing chemotherapy for breast cancer and experiences severe nausea and vomiting. Which antiemetic, recognized for its minimal extrapyramidal side effects, would be appropriate for her condition?
- A. Metoclopramide
- B. Ondansetron (Correct Answer)
- C. Promethazine
- D. Prochlorperazine
Palliative Care in Gynecologic Oncology Explanation: ***Ondansetron***
- **Ondansetron** is a 5-HT3 receptor antagonist, highly effective against chemotherapy-induced nausea and vomiting (CINV) due to its action on serotonin receptors in the **chemoreceptor trigger zone** and **gastrointestinal tract**.
- It is known for its favorable side effect profile, with **minimal to no extrapyramidal symptoms**, making it a preferred choice in patients where such effects are a concern.
*Metoclopramide*
- While effective against nausea and vomiting, **metoclopramide** (a D2 receptor antagonist) can cause **extrapyramidal symptoms** such as **dystonia** and **tardive dyskinesia**, especially with prolonged use or higher doses.
- Its mechanism of action includes both prokinetic effects and central antiemetic action, but its side effect profile makes it less ideal when avoiding extrapyramidal symptoms is a priority.
*Promethazine*
- **Promethazine** is a first-generation antihistamine with antiemetic properties, but it can cause significant **sedation** and has some **anticholinergic side effects**.
- Although its extrapyramidal risk is lower than some other drugs, it's not the primary choice for chemotherapy-induced nausea due to its sedative effects and generally less potent antiemetic action for CINV compared to 5-HT3 antagonists.
*Prochlorperazine*
- **Prochlorperazine** is a phenothiazine antipsychotic with strong antiemetic effects, acting primarily as a **dopamine receptor antagonist**.
- It carries a significant risk of **extrapyramidal side effects**, including **acute dystonia** and **parkinsonism**, making it less suitable when such side effects must be strictly avoided.
Palliative Care in Gynecologic Oncology Indian Medical PG Question 10: Match List-I with List-II and select the correct answer using the code given below the Lists:
- A. A→4 B→3 C→1 D→2
- B. A→4 B→2 C→3 D→1
- C. A→3 B→4 C→1 D→2
- D. A→4 B→1 C→3 D→2 (Correct Answer)
Palliative Care in Gynecologic Oncology Explanation: **A→4 B→1 C→3 D→2**
- This option correctly matches each endocrine gland with its primary hormone: the **pineal gland** produces **melatonin**, the **testis** produces **testosterone**, the **adrenal gland** produces **cortisol**, and the **ovary** produces **estrogen**.
- These pairings are fundamental to understanding the basic functions of the endocrine system.
*A→4 B→3 C→1 D→2*
- This option incorrectly matches the **testis** with **cortisol** (should be testosterone) and the **adrenal gland** with **melatonin** (should be cortisol).
- Cortisol is a steroid hormone produced by the adrenal cortex, while melatonin from the pineal gland regulates sleep-wake cycles.
*A→4 B→2 C→3 D→1*
- This option incorrectly matches the **testis** with **estrogen** (should be testosterone) and the **ovary** with **melatonin** (should be estrogen).
- Estrogen is the primary female sex hormone, while testosterone is the primary male sex hormone.
*A→3 B→4 C→1 D→2*
- This option incorrectly matches the **pineal gland** with **cortisol** (should be melatonin) and the **testis** with **estrogen** (should be testosterone).
- The pineal gland is known for its role in circadian rhythms through melatonin production, not stress response hormones like cortisol.
More Palliative Care in Gynecologic Oncology Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
